SG52470A1 - Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof - Google Patents
Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereofInfo
- Publication number
- SG52470A1 SG52470A1 SG1996004996A SG1996004996A SG52470A1 SG 52470 A1 SG52470 A1 SG 52470A1 SG 1996004996 A SG1996004996 A SG 1996004996A SG 1996004996 A SG1996004996 A SG 1996004996A SG 52470 A1 SG52470 A1 SG 52470A1
- Authority
- SG
- Singapore
- Prior art keywords
- chelates
- conjugates
- formation
- chelating agents
- macrocyclic chelating
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000002738 chelating agent Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86807892A | 1992-04-13 | 1992-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG52470A1 true SG52470A1 (en) | 1998-09-28 |
Family
ID=25351031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996004996A SG52470A1 (en) | 1992-04-13 | 1993-04-13 | Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0662842A1 (de) |
| JP (1) | JPH07505886A (de) |
| AU (1) | AU694074B2 (de) |
| CA (1) | CA2117775A1 (de) |
| NO (1) | NO943847L (de) |
| SG (1) | SG52470A1 (de) |
| WO (1) | WO1993020852A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69433534T2 (de) * | 1994-09-07 | 2004-07-08 | The Dow Chemical Co., Midland | Verfahren zur herstellung von makrozyklischen agentien und ihren chelaten und konjugaten |
| ES2486845T3 (es) * | 2003-04-15 | 2014-08-19 | Algeta Asa | Torio-227 para ser usado en radioterapia de enfermedad de partes blandas |
| US20090208421A1 (en) | 2008-02-19 | 2009-08-20 | Dominique Meyer | Process for preparing a pharmaceutical formulation of contrast agents |
| JP5376130B2 (ja) * | 2009-03-24 | 2013-12-25 | 独立行政法人日本原子力研究開発機構 | 抗体標識が可能な無担体１７７Ｌｕの分離精製法 |
| GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
| US4994560A (en) * | 1987-06-24 | 1991-02-19 | The Dow Chemical Company | Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies |
| JP2831073B2 (ja) * | 1988-06-24 | 1998-12-02 | ザ ダウ ケミカル カンパニー | 大環状二官能キレート剤、その錯体及びそれらの抗体接合体 |
| JP2930708B2 (ja) * | 1988-12-23 | 1999-08-03 | ザ ダウ ケミカル カンパニー | イソチオシアナト官能化金属錯体の製造方法 |
-
1993
- 1993-04-13 CA CA 2117775 patent/CA2117775A1/en not_active Abandoned
- 1993-04-13 EP EP93912231A patent/EP0662842A1/de not_active Ceased
- 1993-04-13 WO PCT/US1993/003483 patent/WO1993020852A2/en not_active Application Discontinuation
- 1993-04-13 SG SG1996004996A patent/SG52470A1/en unknown
- 1993-04-13 JP JP5518572A patent/JPH07505886A/ja active Pending
-
1994
- 1994-10-12 NO NO943847A patent/NO943847L/no unknown
-
1997
- 1997-07-09 AU AU28563/97A patent/AU694074B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0662842A1 (de) | 1995-07-19 |
| JPH07505886A (ja) | 1995-06-29 |
| WO1993020852A3 (en) | 1993-11-25 |
| CA2117775A1 (en) | 1993-10-28 |
| AU694074B2 (en) | 1998-07-09 |
| NO943847D0 (no) | 1994-10-12 |
| AU677006B2 (en) | 1997-04-10 |
| AU2856397A (en) | 1997-10-30 |
| NO943847L (no) | 1994-10-12 |
| AU4285093A (en) | 1993-11-18 |
| WO1993020852A2 (en) | 1993-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU912755D0 (en) | Water-soluble taxole derivatives and process for producing said compounds | |
| EG25852A (en) | Teracyclic derivatives process of preparation | |
| HU9301879D0 (en) | Process and compositions for disinfecting contact-lenses | |
| HU911789D0 (en) | Process for producing derivatives of triazolo-triazine and pyrazolo-triazine | |
| HU910354D0 (en) | Process for producing 4-isoxazole-carboxamide derivatives and paharmaceutical preparatives containing such active agents | |
| SK60895A3 (en) | Taxane derivatives and process for their preparation | |
| GB2240104B (en) | New arylvinylamide derivatives and process for their preparation | |
| HU9802965D0 (en) | Iminothiazolidine intermediers and process for their preparation | |
| SG52470A1 (en) | Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof | |
| IL107698A0 (en) | Process for preparing immunoconjugates | |
| HUT72019A (en) | Process for preparation of 3-amino-pyridines from nitropyridines | |
| GB2272702B (en) | A process for the preparation of aluminium-heavy metal mixed complexes | |
| EP0485749A3 (en) | Chemical modification of antibodies for creating of immunoconjugates | |
| EP0444708A3 (en) | Process for preparation of beta-lactam derivatives | |
| ZA911927B (en) | Labdanes and process for their preparation | |
| OA09959A (en) | Process for preparing 3-acylestratrienes and acylbenzenes | |
| GB9316352D0 (en) | Process for the preparation of 9-amino camptothecin | |
| EP0588229A3 (en) | Macrocyclic chelating agents for the preparation of technetium or rhenium complexes | |
| AU2904789A (en) | Macrocyclic chelating agents and chelates thereof | |
| AU3216289A (en) | Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal | |
| GB9201224D0 (en) | Difluoromethylenandrostenone derivatives and process for their preparation | |
| HU208085B (en) | Process for producing pharmaceutical compositions comprising iron | |
| GB9201286D0 (en) | 3-methyleneandrostane derivatives and process for their preparation | |
| GB9224188D0 (en) | Imidazolyalkyl-imidazolidinone derivatives and process for their preparation | |
| HK1007159A1 (en) | A process for the preparation of aluminium-heavy metal mixed complexes |